Friday, May 08, 2020 5:32:18 PM
First, as memory seems to be so short on OTC and some new posters that don’t know the company (and pretend having the revealed reality) have come here saying there is no DD, that the supporters only say everything is good because we are heavily invested in VRUS, etc., I would like to remind the following:
1. In January 2, 2017, when Anshu entered into an agreement with the company to replace the previous CEO and to spinoff from a defunct company, he came not only as a CEO, but as a PARTNER and a CEO. So his stock based compensation maybe should not be called that way (that originates all the false claims that he is receiving too much, not thinking in shareholders, blah, blah, blah) because what we are seeing in non-cash charges is a realization of the partnership initial agreement of him being an owner of a percentage of the company, not a salary. Also consider the following to reinforce what I’m saying:
a. Stock based compensations are normally awarded as shares that the employee receives without having to pay. In Anshu’s case, he is not receiving shares, he is receiving warrants at an exercise price of 0.006, which is very different. In order to receive all the shares he is entitled to receive, he would have to pay that amount per share, which is almost the same market price we have now.
b. With the spinoff from a dead company with zero value Anshu started from zero revenues and customers a 100% new business. If it wasn’t for him, we would not have anything of what we have now, just think about that for a second. Also every million he brings to the company that allows him receive 7.5 million shares until he completes 20% of ownership stays with the company after he doesn’t receive anymore shares.
c. It is normal to have capitalist partners that get together with working partners to start a new business. He is putting his work in exchange for participation in the company, but also paying to receive his participation, so I don’t see why that is too much for him, I actually see the opposite.
2. When Anshu first signed the mentioned agreement in January 2, 2017, he was entitled to receive up to 90% of the Outstanding shares of the company based on Revenue increase.
https://www.otcmarkets.com/filing/html?id=11772773&guid=JmrHUFgG6XOG13h
And that was modified to only 20% as can be seen in the 8-K/A from January 31 2017. So whoever is saying that is surprised with Anshu’s warrants is wrong. This is not new and nobody should be surprised. Actually conditions have been changing to be more positive for shareholders and less positive for him.
https://www.otcmarkets.com/filing/html?id=11812317&guid=JmrHUFgG6XOG13h
4. Then Andrew Garnock came and invested with a note and warrant to purchase stock at 0.0025 conversion price and we call him our Angel investor. But who brought Andrew Garnock to our company? Anshu. Also, Anshu’s warrants are exercisable at 0.006 per share (more than two times the price for Andrew Garnock) and additional to that, works for us incessantly 24/7. Maybe it’s worth calling Anshu our other Angel investor and Angel CEO.
Also consider that all revenue has come thanks to Anshu, but he is receiving shares for that until he gets 20% of ownership and that doesn’t mean Revenue brought by him will not continue with the company year after year.
5. With the last changes he is again giving up part of his benefits as he puts a limit with the Outstanding shares now, so if in the future OS increases he will not obtain more and will end up having less than 20%. So guess what, he has the same type of shares as us and doesn’t want any type of dilution because his 20% will be affected
So the ones that keep on staining Anshu’s honor should consider stopping to do it even if legal consequences don’t scare them.
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM